Australian Operations
Include All CSL Behring Country Sites


Human coagulation factor IX, powder for injection

For more information about MonoFIX-VF, please visit the New Zealand Blood Service website.

For information about haemophilia care in New Zealand, visit the Haemophilia Foundation of New Zealand  website.
For information on how to prepare MonoFIX-VF using the Mix2Vial™
MonoFIX-VF is a freeze-dried preparation containing human coagulation factor IX, a protein which is essential for normal blood clotting.

MonoFIX-VF is used to replace factor IX in people with haemophilia B, a bleeding disorder in which there are reduced levels of factor IX. People with low levels of factor IX may have difficulty forming blood clots, and these clots may take longer to form. Sometimes, people with low levels of factor IX may bleed spontaneously into their joints or muscles.

MonoFIX-VF is supplied as a freeze-dried powder which is dissolved with Water for Injections and then injected into a vein. Each vial of MonoFIX-VF is packaged with one vial of Water for Injections and a plastic Mix2Vial™ filter transfer set that is used to transfer the Water for Injections into the MonoFIX-VF vial.

Data sheet
The data sheet contains information to ensure the safe and effective use of a medicine. This document is approved by Medsafe, the New Zealand Medicines and Medical Devices Safety Authority. It is made available by CSL Behring for you if you are a:
  1. qualified healthcare professional; or
  2. consumer wanting further information on the product; and agree to consult with your healthcare professional if you have any questions in relation to the Data sheet.

PDF icon MonoFIX-VF Data Sheet (PDF, 0.11MB)

® Registered Trademark of CSL Limited, ™ Trade mark of Medimop Medical Projects Ltd